Cellectis' Annual Shareholders General Meeting to be Held on June 28, 2024
Cellectis(CLLS) Newsfilter·2024-05-29 20:30NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 28, 2024 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life- sav ...